Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Ledergerber B, Weber R, Egger M, Schmid P, Bernasconi E, Cavassini M, Hirschel B, Elzi L, Lehmann R, Rickenbach M, Furrer H, Swiss HIV Cohort Study. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9.
Jul 1, 2007Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
Jul 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 45:111-9
Ledergerber Bruno, Weber Rainer, Egger Matthias, Schmid Patrick, Bernasconi Enos, Cavassini Matthias, Hirschel Bernard, Elzi Luigia, Lehmann Roger, Rickenbach Martin, Furrer Hansjakob, Swiss HIV Cohort Study
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
Vernazza P, Daneel S, Schiffer V, Decosterd L, Fierz W, Klimkait T, Hoffmann M, Hirschel B. The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS (London, England) 2007; 21:1309-15.
Jun 19, 2007The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial
Jun 19, 2007AIDS (London, England) 2007; 21:1309-15
Vernazza Pietro, Daneel Synove, Schiffer Véronique, Decosterd Laurent, Fierz Walter, Klimkait Thomas, Hoffmann Matthias, Hirschel Bernard
[Inflammation-induced upper abdominal pain. A 39-year-old economist]
Stöckli R, Rafeiner P. [Inflammation-induced upper abdominal pain. A 39-year-old economist]. Praxis 2007; 96:507-8.
Mar 28, 2007[Inflammation-induced upper abdominal pain. A 39-year-old economist]
Mar 28, 2007Praxis 2007; 96:507-8
Stöckli R, Rafeiner Philippe
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Swiss HIV Cohort Study. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials 2007; 8:77-85.
Mar 1, 2007Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study
Mar 1, 2007HIV clinical trials 2007; 8:77-85
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, Swiss HIV Cohort Study
Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Hoffmann M, Reichmuth M, Fantelli K, Schoch O, Fierz W, Furrer H, Vernazza P. Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS (London, England) 2007; 21:390-2.
Jan 30, 2007Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients
Jan 30, 2007AIDS (London, England) 2007; 21:390-2
Hoffmann Matthias, Reichmuth Markus, Fantelli Karin, Schoch Otto, Fierz Walter, Furrer Hansjörg, Vernazza Pietro
[Osteoporosis: basics and pitfalls]
Rafeiner P. [Osteoporosis: basics and pitfalls]. Praxis 2007; 96:101-6.
Jan 24, 2007[Osteoporosis: basics and pitfalls]
Jan 24, 2007Praxis 2007; 96:101-6
Rafeiner Philippe
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Wolbers M, Bucher H, Kaufmann G, Bernasconi E, Vernazza P, Hasse B, Cavassini M, Furrer H, Hirschel B, Battegay M, Swiss HIV Cohort Study. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy 2007; 12:889-97.
Jan 1, 2007CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy
Jan 1, 2007Antiviral therapy 2007; 12:889-97
Wolbers Marcel, Bucher Heiner C, Kaufmann Gilbert, Bernasconi Enos, Vernazza Pietro, Hasse Barbara, Cavassini Matthias, Furrer Hansjakob, Hirschel Bernard, Battegay Manuel, Swiss HIV Cohort Study
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study
Simcock M, Furrer H, Hirschel B, Vernazza P, Sendi P, Rickenbach M, Bucher H, Battegay M, Koller M, Moirandat-Rytz S, Terziroli B, Blasko M, Karrer U, Bertisch B, Pless M, Blumer L, Vora S, Robinson J, Bernasconi E, Swiss HIV Cohort Study. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:931-9.
Jan 1, 2007Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study
Jan 1, 2007Antiviral therapy 2007; 12:931-9
Simcock Mathew, Furrer Hansjakob, Hirschel Bernard, Vernazza Pietro, Sendi Pedram, Rickenbach Martin, Bucher Heiner C, Battegay Manuel, Koller Michael T, Moirandat-Rytz Sophie, Terziroli Benedetta, Blasko Monika, Karrer Urs, Bertisch Barbara, Pless Miklos, Blumer Liisa, Vora Samir, Robinson James Owen, Bernasconi Enos, Swiss HIV Cohort Study
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification
Keiser O, Furrer H, Telenti A, Rickenbach M, Vernazza P, Bernasconi E, Hirschel B, Hirsch H, Opravil M, Fellay J, Swiss HIV Cohort Study. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antiviral therapy 2007; 12:1157-64.
Jan 1, 2007Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification
Jan 1, 2007Antiviral therapy 2007; 12:1157-64
Keiser Olivia, Furrer Hansjakob, Telenti Amalio, Rickenbach Martin, Vernazza Pietro, Bernasconi Enos, Hirschel Bernard, Hirsch Hans H, Opravil Milos, Fellay Jacques, Swiss HIV Cohort Study
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Fux C, Furrer H, Elzi L, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Hirschel B, Bucher H, Wolbers M, Simcock M, Swiss HIV Cohort Study. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy 2007; 12:1165-73.
Jan 1, 2007Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study
Jan 1, 2007Antiviral therapy 2007; 12:1165-73
Fux Christoph A, Furrer Hansjakob, Elzi Luigia, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Hirschel Bernard, Bucher Heiner C, Wolbers Marcel, Simcock Mathew, Swiss HIV Cohort Study
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Elzi L, Furrer H, Rickenbach M, Bernasconi E, Schmid P, Cavassini M, Hirschel B, Weber R, Schlegel M, Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102.
Jan 1, 2007Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
Jan 1, 2007Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007; 44:94-102
Elzi Luigia, Furrer Hansjakob, Rickenbach Martin, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Schlegel Matthias, Swiss HIV Cohort Study
Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Wunder D, Furrer H, Mueller B, Bernasconi E, Schmid P, Elzi L, Cavassini M, Hirschel B, Mueller N, Fux C, Bersinger N, Swiss HIV Cohort Study. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy 2007; 12:261-5.
Jan 1, 2007Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy
Jan 1, 2007Antiviral therapy 2007; 12:261-5
Wunder Dorothea M, Furrer Hansjakob, Mueller Bruno, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Mueller Nicolas J, Fux Christoph A, Bersinger Nick A, Swiss HIV Cohort Study
An unexpected and fatal differential diagnosis of acute bilateral leg pain
Abela E, Flügel D, Würmli L, Boggian K, Schaaf J, Tettenborn B. An unexpected and fatal differential diagnosis of acute bilateral leg pain. Schw Arch Neurol Psychiatr 2007; 158:184.
Jan 1, 2007An unexpected and fatal differential diagnosis of acute bilateral leg pain
Jan 1, 2007Schw Arch Neurol Psychiatr 2007; 158:184
Abela E, Flügel Dominique, Würmli L, Boggian K, Schaaf J, Tettenborn Barbara
Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report
Nicca D, Moody K, Elzi L, Spirig R. Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report. The Journal of the Association of Nurses in AIDS Care : JANAC 2007; 18:44-53.
Jan 1, 2007Comprehensive clinical adherence interventions to enable antiretroviral therapy: a case report
Jan 1, 2007The Journal of the Association of Nurses in AIDS Care : JANAC 2007; 18:44-53
Nicca Dunja, Moody Kimberly, Elzi Luigia, Spirig Rebecca
Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study
Keiser O, Aebi-Popp K, Bernasconi E, Schmid P, Elzi L, Zinkernagel A, Zellweger C, Chapuis-Taillard C, Wunder D, Martinez de Tejada B, Rickenbach M. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. Journal of acquired immune deficiency syndromes (1999) 2006; 43:550-5.
Dec 15, 2006Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study
Dec 15, 2006Journal of acquired immune deficiency syndromes (1999) 2006; 43:550-5
Keiser Olivia, Aebi-Popp Karoline, Bernasconi Enos, Schmid Patrick, Elzi Luigia, Zinkernagel Annelies S, Zellweger Claudine, Chapuis-Taillard Caroline, Wunder Dorothea, Martinez de Tejada Begoña, Rickenbach Martin
[A 81-year-old patient with physiotherapy-resistant upper limb tenderness]
von Garnier C, Bär D, Daikeler T, Rafeiner P. [A 81-year-old patient with physiotherapy-resistant upper limb tenderness]. Praxis 2006; 95:1768-70.
Nov 8, 2006[A 81-year-old patient with physiotherapy-resistant upper limb tenderness]
Nov 8, 2006Praxis 2006; 95:1768-70
von Garnier C, Bär D, Daikeler T, Rafeiner Philippe
[Acute fever in infants]
Kahlert C, Nadal D. [Acute fever in infants]. Therapeutische Umschau. Revue thérapeutique 2006; 63:659-65.
Oct 1, 2006[Acute fever in infants]
Oct 1, 2006Therapeutische Umschau. Revue thérapeutique 2006; 63:659-65
Kahlert Christian, Nadal D
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, Wolbers M, Ungsedhapand C, Swiss HIV Cohort Study. Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV medicine 2006; 7:404-10.
Sep 1, 2006Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study
Sep 1, 2006HIV medicine 2006; 7:404-10
Glass T R, Bucher H C, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza Pietro, Weber R, Wolbers M, Ungsedhapand C, Swiss HIV Cohort Study
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Ananworanich J, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B, Staccato Study Group, Bernasconi E, Vernazza P, Nüesch R, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Swiss HIV Cohort Study. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet 2006; 368:459-65.
Aug 5, 2006CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Aug 5, 2006Lancet 2006; 368:459-65
Ananworanich Jintanat, Leduc Dominic, Satchell Claudette, Yerly Sabine, Perrin Luc, Hill Andrew, Perneger Thomas, Phanuphak Praphan, Furrer Hansjakob, Cooper David, Ruxrungtham Kiat, Hirschel Bernard, Staccato Study Group, Bernasconi Enos, Vernazza Pietro, Nüesch Reto, Gayet-Ageron Angèle, Le Braz Michelle, Prasithsirikul Wisit, Chetchotisakd Ploenchan, Kiertiburanakul Sasisopin, Munsakul Warangkana, Raksakulkarn Phitsanu, Tansuphasawasdikul Somboon, Sirivichayakul Sunee, Cavassini Matthias, Karrer Urs, Genné Daniel, Swiss HIV Cohort Study
Hypothermer “Kamelhöcker” – die Osborn-Welle
Hoffmann M, Hasse B, Widmer F. Hypothermer “Kamelhöcker” – die Osborn-Welle. Swiss Med Forum 2006; 6:907.
Aug 1, 2006Hypothermer “Kamelhöcker” – die Osborn-Welle
Aug 1, 2006Swiss Med Forum 2006; 6:907
Hoffmann Matthias, Hasse Barbara, Widmer Fritz